הכנסות ממכירות החברה prenetics.com (PRE)

The resilience of Prenetics Global (PRE) is based on overcoming the post-pandemic slump and expanding into new niches. The company's sales figures confirm this trend, with the current value standing at 0.14. Growth is driven by investments in preventive oncology and genetics in Asia, while AI-powered robotic sequencers automate DNA analysis, maintaining expert physician control over final diagnoses.

Daily revenue measures the actual cash inflow rate, allowing for an assessment of the business's real liquidity. The current aggregate sales level of Prenetics Global (PRE) on GURU.Markets confirms stable demand for consumer DNA tests and cancer screening. Sales dynamics demonstrate how operating income offsets the costs of clinical product validation. Analyzing this chart helps identify asset undervaluation in a timely manner, which is critical for balancing the risks of an overheated business against capitalization.